Author:
Lieberman Abraham N.,Goldstein Menek
Reference82 articles.
1. Hyperactivity of remaining neurones after partial destruction of the nigro-striatal dopaminergic system in the rat;AGID;Nature (London),1973
2. Chemical or electrolytic lesions of the substantia nigra: early effects on neostriatal dopamine metabolism;AGID;Brain Research,1974
3. Dopaminergic agonist RO 8–4650 in Parkinson's disease. 1. Patients treated with dopa;BIRKET-SMITH;Acta Neurologica Scandinavia,1978
4. Potentiation of antikinetic effect after L-dopa treatment by an inhibitor of MAO-B, deprenil;BIRKMAYER;Journal of Neural Transmissions,1975
5. Parkinsonism treated with 3–0-methyldopa;CALNE;Clinical Pharmacology and Therapeutics,1973
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pediatric Iatrogenic Movement Disorders;Seminars in Pediatric Neurology;2018-04
2. Rationale for Use of Dopamine Agonists in Parkinson's Disease: Review of Ergot Derivatives;Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques;1999-08